Education
About Us
Working with TipRanks
Follow Us
Wanbury Limited (IN:WANBURY)
:WANBURY
WANBURY Stock Chart & Stats
₹235.40
-₹13.70(-4.99%)
At close: 4:00 PM EST
₹235.40
-₹13.70(-4.99%)
Day’s Range― - ―
52-Week Range₹155.00 - ₹330.00
Previous CloseN/A
Volume54.35K
Average Volume (3M)8.26K
Market Cap
₹9.19B
Enterprise Value₹10.84B
Total Cash (Recent Filing)₹129.60M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)13.1
Beta2.45
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.50
Shares Outstanding34,939,400
10 Day Avg. Volume8,584
30 Day Avg. Volume8,255
Financial Highlights & Ratios
PEG Ratio-0.63
Price to Book (P/B)14.81
Price to Sales (P/S)1.46
P/FCF Ratio-38.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin RecoverySustained revenue growth with improving gross, EBIT and EBITDA margins indicates the company is restoring operational efficiency and pricing power. This durability supports stronger cash generation potential and provides room to reinvest in capacity or product development over the next several quarters.
Restored Shareholders' EquityReversal from negative to positive stockholders' equity signals meaningful balance-sheet repair, reducing insolvency risk and improving access to capital. A healthier equity base strengthens creditor confidence and underpins long-term financing flexibility for growth or deleveraging initiatives.
Operating Cash Flow StrengthImproving operating cash flow and a strong OCF-to-net-income ratio show the company is converting earnings into cash more effectively. That operational cash focus supports working capital needs and can fund near-term investments, improving resilience while management works toward positive free cash flow.
Bears Say
High Financial LeverageElevated debt-to-equity and a low equity ratio leave the company exposed to interest-rate rises and cyclical demand shocks. High leverage constrains strategic flexibility, increases mandatory interest costs, and limits ability to absorb setbacks without further equity or refinancing, raising medium-term risk.
Persistent Negative Free Cash FlowDespite improving operating cash flow, recurring negative free cash flow implies cash outlays exceed internal generation after capex. This structural shortfall forces reliance on external financing or asset sales, increasing refinancing risk and potentially delaying investments or margin-enhancing initiatives.
Profitability InstabilityVolatile net profit margins and negative recent EPS growth reflect inconsistent ability to translate sales into sustainable net earnings. This variability complicates planning, undermines retained-earnings buildup needed to lower leverage, and may signal exposure to input-cost swings or pricing pressure in core products.
Wanbury Limited News
WANBURY FAQ
What was Wanbury Limited’s price range in the past 12 months?
Wanbury Limited lowest stock price was ₹155.00 and its highest was ₹330.00 in the past 12 months.
What is Wanbury Limited’s market cap?
Wanbury Limited’s market cap is ₹9.19B.
When is Wanbury Limited’s upcoming earnings report date?
Wanbury Limited’s upcoming earnings report date is May 14, 2026 which is in 77 days.
How were Wanbury Limited’s earnings last quarter?
Wanbury Limited released its earnings results on Feb 05, 2026. The company reported ₹4.5 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.5.
Is Wanbury Limited overvalued?
According to Wall Street analysts Wanbury Limited’s price is currently Overvalued.
Does Wanbury Limited pay dividends?
Wanbury Limited pays a Notavailable dividend of ₹1 which represents an annual dividend yield of N/A. See more information on Wanbury Limited dividends here
What is Wanbury Limited’s EPS estimate?
Wanbury Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wanbury Limited have?
Wanbury Limited has 34,939,400 shares outstanding.
What happened to Wanbury Limited’s price movement after its last earnings report?
Wanbury Limited reported an EPS of ₹4.5 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.532%.
Which hedge fund is a major shareholder of Wanbury Limited?
Currently, no hedge funds are holding shares in IN:WANBURY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Technical Analysis
Kilitch Drugs (India) Limited
―
Kopran Limited
―
Lincoln Pharmaceuticals Ltd
―
Sakar Healthcare Ltd
―
Themis Medicare Limited
―